Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States.

ABSTRACT:

Background

The rising prevalence of hepatitis C virus (HCV) infection and the availability of direct acting antivirals for HCV treatment has prompted a public health goal of HCV eradication. Despite the availability of treatment for HCV, treatment programs have generally excluded pregnant individuals. Our objective was to query patients and clinicians to identify barriers to including pregnant individuals in HCV treatment programs.

Methods and findings

This qualitative investigation included obstetricians and previously/currently pregnant individuals with HCV. Participants completed interviews regarding knowledge of and attitudes towards HCV treatment and perceived barriers to treatment during pregnancy. Data were analyzed using the constant comparative method. Obstetricians

SUBMITTER: Yee LM 

PROVIDER: S-EPMC9674123 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature